PubMed COVID-19 Clinical Care

No abstract

Recovered COVID-19 patients frequently suffer of cognitive disorders. Several etiopathogenetic mechanisms have been considered for the brain complications in COVID-19 but results are uncertain. Amongst them, an olfactory route to SARS-CoV-2 brain

CONCLUSIONS: Risk factors for severe COVID-19 outcomes were similar throughout pandemic epochs in unvaccinated people with RD. Ongoing efforts, including vaccination, are needed to reduce COVID-19 severity in this population, particularly in those

COVID-19 vaccine uptake in the United States has proved challenging. A deeper characterization extending beyond demographics and political ideologies of those hesitating or resisting is needed to guide ongoing conversations. This study examined

CONCLUSIONS: The results identify several barriers and facilitators for nursing home leaders' behaviour for infection control. The results confirm the importance of supporting the leaders' resilience and crisis leadership while working in the

CONCLUSION: In direct comparisons, grade of suspected seizure severity was lower in the Non-1st Group than in the 1st Group.

The multifaceted interplay between neurodegenerative pathologies, including Alzheimer's disease (AD), and the highly virulent severe acute respiratory syndrome coronavirus (SARS-CoV), is implicated in various conditions. AD and SARS-CoV pathogenesis

The Coronavirus Disease 2019 (COVID-19) pandemic continues to infect people worldwide. While the vaccinated population has been increasing, the rising breakthrough infection persists in the vaccinated population. For living with the virus, the

Several countries have weakened the carbon emission objectives to immediately revive the economy in the post-COVID-19 era. Therefore, it is a challenge worth addressing to readjust the economic development and carbon emissions after the COVID-19

No abstract